Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for qualitative or quantitative protein defects in neuromuscular diseases has been reported in the published literature.
No clinical trials have been registered for qualitative or quantitative protein defects in neuromuscular diseases.
201 publications have been identified in PubMed for qualitative or quantitative protein defects in neuromuscular diseases. Kisho has analyzed 89 by research type. Research spans Other (38%), Basic Science / Preclinical (17%), and Review / Meta-Analysis (15%).
Research Type | Count | % of Total |
|---|---|---|
Other research | 34 | 38% |
Data assembled from 3 of 12 sources · Last updated Oct 3, 2026, 10:46 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Laboratory research |
15 |
17% |
Research summaries | 13 | 15% |
Testing and diagnosis research | 12 | 13% |
Disease patterns and progression | 8 | 9% |
New treatment approaches | 3 | 3% |
Patient case studies | 2 | 2% |
Clinical study results | 2 | 2% |
Jiang X (2026). [PMID: 41643021](https://pubmed.ncbi.nlm.nih.gov/41643021/). *Science (New York, N.Y.)*. [Basic Science / Preclinical]
Bashirov R (2026). [PMID: 42178473](https://pubmed.ncbi.nlm.nih.gov/42178473/). *Adv Exp Med Biol*. [Review / Meta-Analysis]
Ishii Y (2026). [PMID: 41447267](https://pubmed.ncbi.nlm.nih.gov/41447267/). *Int J Qual Stud Health Well-being*. [Other]
Zhou L (2026). [PMID: 41928070](https://pubmed.ncbi.nlm.nih.gov/41928070/). *Nursing open*. [Review / Meta-Analysis]
Hoffman RJ (2026). [PMID: 41592939](https://pubmed.ncbi.nlm.nih.gov/41592939/). *Archives of disease in childhood*. [Review / Meta-Analysis]
Brown B (2025). [PMID: 40560025](https://pubmed.ncbi.nlm.nih.gov/40560025/). *Pharmacy (Basel)*. [Other]
Urbina-Garcia A (2025). [PMID: 39833989](https://pubmed.ncbi.nlm.nih.gov/39833989/). *Int J Qual Stud Health Well-being*. [Other]
Ostrolenk A (2025). [PMID: 40320659](https://pubmed.ncbi.nlm.nih.gov/40320659/). *International journal of qualitative studies on health and well-being*. [Basic Science / Preclinical]
Allam A (2025). [PMID: 38990089](https://pubmed.ncbi.nlm.nih.gov/38990089/). *European journal of paediatric dentistry*. [Review / Meta-Analysis]
Xu C (2025). [PMID: 39988971](https://pubmed.ncbi.nlm.nih.gov/39988971/). *Molecular genetics & genomic medicine*. [Diagnostic / Biomarker]
AI-curated news mentioning qualitative or quantitative protein defects in neuromuscular diseases
Updated Jan 26, 2026
The Muscular Dystrophy Association (MDA) is celebrating Rare Disease Day on February 28 by sharing community stories that highlight advancements in research, care, and advocacy for individuals with rare neuromuscular diseases. This initiative aims to enhance awareness and engagement among those affected by muscular dystrophy, ALS, and related conditions.